Thermi

7 articles about Thermi

• Thermi Receives Notice Of Complete And Satisfactory Closure Of FDA's "Vaginal Rejuvenation" Inquiry

  11/15/2018

  Thermi®, an Almirall, S.A. company, today announced that it has received a notice of completion to a U.S. Food and Drug Administration (FDA) inquiry on products used in "vaginal rejuvenation" procedures.

• THERMI® LAUNCHES ARVATI™, powered by Thermi®, with newest advances in True Temperature Controlled Radiofrequency Technology

  9/4/2018

  New platform with patented technology optimizes delivery of temperature-controlled monopolar radiofrequency using continuous wave technology with next-generation intelligent auto-modulation algorithms to maximize consistency and control

• Thermi's Temperature-Controlled Radiofrequency Technology Approved In Canada To Treat Dermal Laxity

  6/12/2018

  Thermi RF treatments in Canada include market leaders ThermiTight®, ThermiSmooth® Face and ThermiRase®, providing significant versatility, value, and control to clinicians

• Thermi's Temperature-Controlled Radiofrequency System Improved Common Vaginal Disorders And Sexual Function, Published Study Shows

  6/6/2018

  ThermiVa® improved atrophic vaginitis, laxity and sexual satisfaction; First data to show better blood flow, new collagen and nerve growth in intimate tissue

• Thermi announces new clinical education and enhanced training platforms for clinicians

  2/26/2018

  Thermi, an Almirall company, has created an innovative medical exchange and clinical training platform to advance the science of temperature-controlled tissue heating technology and best practices. This includes the launch of thirty-six (36) National Centers of Excellence (COE) sites, Thermi P.R.E.P. National Academy Platform, and a newly organized Medical Affairs organization led by Dr. Tara Margarella.

• Thermi Launches New Injectable RF Electrode For ThermiRF Device

  10/2/2017

• Paul Herchman, Co-Founder Of Thermi, Joins Board Of Ideal Implant

  7/31/2017